Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174.

Article  PubMed  PubMed Central  Google Scholar 

Rabeneck L, Chiu H-M, Senore C. International perspective on the burden of colorectal cancer and public health effects. Gastroenterology. 2020;158(2):447–52.

Article  PubMed  Google Scholar 

Shahbaz SK, Koushki K, Ayati SH, Bland AR, Bezsonov EE, Sahebkar A. Inflammasomes and colorectal cancer. Cells. 2021;10:9.

Google Scholar 

Hajibabaie F, Abedpoor N, Assareh N, Tabatabaiefar MA, Shariati L, Zarrabi A. The importance of SNPs at miRNA binding sites as biomarkers of gastric and colorectal cancers: a systematic review. J Person Med. 2022;12(3):456.

Article  Google Scholar 

Li J, Chen D, Shen M. Tumor microenvironment shapes colorectal cancer progression, metastasis, and treatment responses. Front Med. 2022;9: 869010.

Article  Google Scholar 

Kaviani E, Hajibabaie F, Abedpoor N, Safavi K, Ahmadi Z, Karimy A. System biology analysis to develop diagnostic biomarkers, monitoring pathological indexes, and novel therapeutic approaches for immune targeting based on maggot bioactive compounds and polyphenolic cocktails in mice with gastric cancer. Environ Res. 2023;238: 117168.

Article  CAS  PubMed  Google Scholar 

Keller D, Windsor A, Cohen R, Chand M. Colorectal cancer in inflammatory bowel disease: review of the evidence. Tech Coloproctol. 2019;23:3–13.

Article  CAS  PubMed  Google Scholar 

Duarte D, Vale N. Combining repurposed drugs to treat colorectal cancer. Drug Disc Today. 2022;27(1):165–84.

Article  CAS  Google Scholar 

Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7(8):573–84.

Article  CAS  PubMed  Google Scholar 

Huang X, Ke K, Jin W, Zhu Q, Zhu Q, Mei R, et al. Identification of genes related to 5-fluorouracil based chemotherapy for colorectal cancer. Front Immunol. 2022;13: 887048.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilkinson NW, Yothers G, Lopa S, Costantino JP, Petrelli NJ, Wolmark N. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol. 2010;17:959–66.

Article  PubMed  PubMed Central  Google Scholar 

Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, et al. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol. 2007;25(29):4569–74.

Article  PubMed  Google Scholar 

Manfredi S, Bouvier A, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. J Br Surg. 2006;93(9):1115–22.

Article  CAS  Google Scholar 

Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA. 2019;69(5):363–85.

PubMed  Google Scholar 

Douillard J, Cunningham D, Roth A, Navarro M, James R, Karasek P, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet. 2000;355(9209):1041–7.

Article  CAS  PubMed  Google Scholar 

Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil–leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol. 2000;18(1):136.

Article  CAS  PubMed  Google Scholar 

Xie P, Mo J-L, Liu J-H, Li X, Tan L-M, Zhang W, et al. Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update. Cell Oncol. 2020;43:989–1001.

Article  CAS  Google Scholar 

Ke MJ, Ji LD, Li YX. Explore prognostic marker of colorectal cancer based on ceRNA network. J Cell Biochem. 2019;120(12):19358–70.

Article  CAS  PubMed  Google Scholar 

Xiang J, Gao L, Jing HY, Liu YX, Wang HF, Chang ZW, et al. Construction of CeRNA regulatory network based on WGCNA reveals diagnosis biomarkers for colorectal cancer. BMC Cancer. 2022;22(1):1–16.

Article  Google Scholar 

Bardelčíková A, Šoltys J, Mojžiš J. Oxidative stress, inflammation and colorectal cancer: an overview. Antioxidants. 2023;12(4):901.

Article  PubMed  PubMed Central  Google Scholar 

Seo CH, Kim J-R, Kim M-S, Cho K-H. Hub genes with positive feedbacks function as master switches in developmental gene regulatory networks. Bioinformatics. 2009;25(15):1898–904.

Article  CAS  PubMed  Google Scholar 

Geng F, Wang Z, Yin H, Yu J, Cao B. Molecular targeted drugs and treatment of colorectal cancer: recent progress and future perspectives. Cancer Biother Radiopharm. 2017;32(5):149–60.

CAS  PubMed  Google Scholar 

Tewari D, Patni P, Bishayee A, Sah AN, Bishayee A, editors. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Seminars in cancer biology; 2022: Elsevier.

Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 2018;27(1):10–21.

Article  CAS  PubMed  Google Scholar 

Berntsen S, Aaronson NK, Buffart L, Börjeson S, Demmelmaier I, Hellbom M, et al. Design of a randomized controlled trial of physical training and cancer (Phys-Can)–the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome. BMC Cancer. 2017;17:1–12.

Article  Google Scholar 

Gerritsen JK, Vincent AJ. Exercise improves quality of life in patients with cancer: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2016;50(13):796–803.

Article  PubMed  Google Scholar 

Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA. 2020;70(4):245–71.

PubMed  Google Scholar 

Duan G-L, Yu X-B. Isolation, purification, characterization, and antioxidant activity of low-molecular-weight polysaccharides from Sparassis latifolia. Int J Biol Macromol. 2019;137:1112–20.

Article  CAS  PubMed  Google Scholar 

Liu J, Zhang X, Zhang J, Yan M, Li D, Zhou S, et al. Research on extraction, structure characterization and immunostimulatory activity of cell wall polysaccharides from Sparassis latifolia. Polymers. 2022;14(3):549.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei X, Cheng F, Liu J, Cheng Y, Yun S, Meng J, et al. Sparassis latifolia polysaccharides inhibit colon cancer in mice by modulating gut microbiota and metabolism. Int J Biol Macromol. 2023;232: 123299.

Article  CAS  PubMed  Google Scholar 

Jayaraman P, Rodrik-Outmezguine V, Millholland J, O’Brien N, Wong C, Diwanji R, et al. Targeting tumor-promoting inflammation (TPI) via the IL-1βpathway for cancer immunotherapy. Cancer Res. 2020;80(16):5640.

Article  Google Scholar 

Peng L, Bian XW, Li DK, Xu C, Wang GM, Xia QY, et al. Large-scale RNA-Seq transcriptome analysis of 4043 cancers and 548 normal tissue controls across 12 TCGA cancer types. Sci Rep. 2015;5(1):13413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Y, Qiu P, Ji Y. TCGA-assembler: open-source software for retrieving and processing TCGA data. Nat Methods. 2014;11(6):599–600.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mocellin S. Microarray technology and cancer gene profiling: Springer Science & Business Media; 2007.

Eilertsen IA, Moosavi SH, Strømme JM, Nesbakken A, Johannessen B, Lothe RA, et al. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Lett. 2020;469:246–55.

Article  CAS  PubMed  Google Scholar 

Canales RD, Luo Y, Willey JC, Austermiller B, Barbacioru CC, Boysen C, et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol. 2006;24(9):1115–22.

Article  CAS  PubMed  Google Scholar 

Alameer A, Chicco D. geoCancerPrognosticDatasetsRetriever: a bioinformatics tool to easily identify cancer prognostic datasets on Gene Expression Omnibus (GEO). Bioinformatics. 2022;38(6):1761–3.

Article  CAS  PubMed  Google Scholar 

Liu DD, Zhang L. Trends in the characteristics of human functional genomic data on the gene expression omnibus, 2001–2017. Lab Invest. 2019;99(1):118–27.

Article  PubMed  Google Scholar 

Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.

Article  PubMed  Google Scholar 

Pereira MB, Wallroth M, Jonsson V, Kristiansson E. Comparison of normalization methods for the analysis of metagenomic gene abundance data. BMC Genomics. 2018;19:1–17.

Article  Google Scholar 

Chen Y, McCarthy D, Robinson M, Smyth GK. edgeR: differential expression analysis of digital gene expression data User's Guide. Bioconductor User's Guide. 2014.

Vlachavas EI, Pilalis E, Papadodima O, Koczan D, Willis S, Klippel S, et al. Radiogenomic analysis of F-18-fluorodeoxyglucose positron emission tomography and gene expression data elucidates the epidemiological complexity of color